Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NanoLinea

NanoLinea
2014 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Provider of therapeutic implant treatment for cardiac ventricular arrhythmia. The company creates medical devices based on carbon nanotube fiber technology.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Hospitals/Inpatient Services
Primary Office
  • 2431 Shakespeare Street
  • Suite 1
  • Houston, TX 77030
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NanoLinea’s full profile, request a free trial.

NanoLinea Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 09-Mar-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NanoLinea Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
TMC Innovation Accelerator/Incubator 000 0000 000000 0

NanoLinea Executive Team (2)

Name Title Board
Seat
Contact
Info
Colin Young Co-Founder & Chief Executive Officer
Mehdi Razavi MD Co-Founder